Qepler | summits & conferences | 3rd Annual Highly Potent APIs Summit, 23-24 February 2023, VIRTUAL
Event Location:
Online Conference
Platform:
HOPIN
Date:
23 - 24 February 2023
Language:
English
Contact Person: Evgenia Makar
Contact Person: Evgenia Makar, Qepler s.r.o.
Contact Person: Denis Polikarpov
Contact Person: Denis Polikarpov, Qepler s.r.o.

Conference Overview

The increasing incidence of cancer and the ever-rising demand for anticancer drugs results in significant growth for the highly potent active pharmaceutical ingredients (HPAPIs) market. The highly toxic properties of HPAPIs, however, present manufacturing and handling challenges. Our meeting facilitates hands-on experience sharing with focus on early process development and scale up, occupational health regulations and safety standards, cross-contamination risk assessment and control, aseptic facilities and equipment maintenance and cleaning, outsourcing and technology transfer strategies.

The featured talks on:

  • HPAPI Process Design and Project Implementation
  • EHS Integration in Capital Projects and Tech Transfer
  • How to handle HPAPIs within Chemical Development (case studies)
  • Future initiatives and advanced manufacturing approachese
  • Flexible Isolator- Occupational Hygiene Experience
  • How to derive health-based exposure limits (HBEL) for ADCs
  • Antibody-Drug Conjugates – antibodies meeting HPAPIs for specific and efficient biopharmaceutical drugs

Meet our Speakers

PREVIOUS EVENT

SNAPSHOT OF ATTENDEES 2020

AbbVie - Acino Pharma AG - Affygility Solutions, LLC - Allergan plc - AMRI ITALY SRL - Andreas Flueckiger Consulting - Angelini Pharma S.p.A. - Bayer AG - Boehringer Ingelheim Pharma GmbH & Co. KG - F. Hoffmann-La Roche AG - Ferring International Center SA - Ferring Pharmaceuticals - Fresenius Kabi Austria GmbH - FUJIFILM Diosynth - GEA Process Engineering nv - Gedeon Richter Plc. - Hebeler Process Solutions LLC - Heraeus Deutschland GmbH & Co. KG - HPAPI Project Services Limited - ILC Dover - Lonza Pharma & Biotech - Merck & Cie - Merck Group - Merck Healthcare KGaA - Merck Performance Materials KGaA - Minakem High Potent - oncomed manufacturing a.s. - Pfizer CentreOne - Pharmacare Premium - Praevena AG - Quinta-Analytica - Raybow Pharmaceutical - SafeBridge Europe, Ltd. - Seqens R&D SERVICES - Servier - Synthon - Takeda - University of Oxford - Vanessa Research Magyarország Kft. - Vetter Pharma-Fertigung GmbH & Co. KG - Zentiva k.s. - Zhejiang Juli Electric Tools Co., Ltd and others.

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookies Policy.